Expert Opinion on Drug Metabolism & Toxicology
Impact Factor Trend (2018–2026)
Clarivate IF trend for Expert Opinion on Drug Metabolism & Toxicology
SCImago Journal Rank citation prestige weighting
112 papers with at least that number of citations each
Aims & Scope
Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
BIOCHEMISTRY & MOLECULAR BIOLOGY
PHARMACOLOGY & PHARMACY
TOXICOLOGY
BIOCHEMISTRY & MOLECULAR BIOLOGY
PHARMACOLOGY & PHARMACY
TOXICOLOGY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisExpert Opinion on Drug Metabolism & Toxicology (acronym: eomt, abbr: EXPERT OPIN. DRUG METAB. TOXICOL, ISSN: 1742-5255) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in England since 2005. The periodical holds a Journal Impact Factor (JIF) of 4.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.986 (Q1), an H-index of 112.
The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 74 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,301 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics